Clinical Drug Experience Knowledgebase

apabetalone (1 trial)

to-o-1001 (1 trial)

adalimumab (humira) (1 trial)

aio-001 (1 trial)

al002 (1 trial)

al01211 (1 trial)

aly688 (1 trial)

ang-3777 (1 trial)

anx005 (1 trial)

anx009 (1 trial)

aom0319 (1 trial)

ap301 (1 trial)

arc-520 (1 trial)

artefenomel (1 trial)

artemether (1 trial)

Avasopasem (2 trials)

avibactam (Avycaz) (1 trial)

bebt-503 (1 trial)

berberine (1 trial)

bld-2660 (1 trial)

bsg005 (1 trial)

bta9881 (1 trial)

bufalin (1 trial)

cannabidiol (Epidiolex) (1 trial)

carboplatin (paraplatin) (1 trial)

cb03-154 (1 trial)

cbp-174 (1 trial)

cbp-307 (1 trial)

cdi-988 (1 trial)

cilastatin (primaxin) (1 trial)

ct-1500 (1 trial)

ct1812 (1 trial)

Cudetaxestat (1 trial)

danicamtiv (1 trial)

deuterated dextromethorphan (1 trial)

dihydroergotamine (D.H.E. 45) (1 trial)

dodecafluoropentane (1 trial)

dronabinol (marinol) (1 trial)

duloxetine (Cymbalta) (1 trial)

Ecnoglutide (1 trial)

elarekibep (1 trial)

enterococcus faecium (1 trial)

epetraborole (1 trial)

eptinezumab (Vyepti) (1 trial)

etelcalcetide (parsabiv) (1 trial)

etx2514 (1 trial)

famotidine (pepcid) (1 trial)

gc4702 (1 trial)

glycovax-002 (1 trial)

gm-60106 (1 trial)

gs-9411 (3 trials)

gsk3008356 (1 trial)

hbi-3000 (1 trial)

hh-006 (1 trial)

hmpl-689 (1 trial)

hsk31858 (1 trial)

hu6 (1 trial)

imipenem (primaxin) (1 trial)

immune globulin (human) (Gamastan) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

inzomelid (1 trial)

izd334 (1 trial)

lactobacillus gasseri (1 trial)

latiglutenase (1 trial)

lidocaine (xylocaine) (1 trial)

lim-0705 (2 trials)

Lirentelimab (1 trial)

lumefantrine (Coartem) (1 trial)

mannitol (Osmitrol) (1 trial)

mf59 (1 trial)

midazolam (versed) (1 trial)

mk-1775 (1 trial)

mmv 533 (1 trial)

mmv688533 (1 trial)

naproxen (naprosyn) (1 trial)

oc514 (1 trial)

octreotide (sandostatin) (1 trial)

olanzapine (zyprexa) (1 trial)

paclitaxel (taxol) (1 trial)

Paltusotine (1 trial)

paroxetine (paxil) (2 trials)

pmg1015 (1 trial)

prv-002 (1 trial)

rdx-002 (1 trial)

rn0191 (1 trial)

ruxolitinib (jakafi) (1 trial)

sars-cov-2 sclamp vaccine (1 trial)

shr-1703 (1 trial)

Sovleplenib (1 trial)

spg302 (1 trial)

streptococcus pyogenes (1 trial)

sulbactam (unasyn) (1 trial)

sumatriptan (zecuity) (1 trial)

tacrolimus (prograf) (1 trial)

telaglenastat (1 trial)

tocilizumab (actemra) (1 trial)

ustekinumab (stelara) (1 trial)

verdinexor (1 trial)